Overview
Postdischarge Thromboprophylaxis for Acutely Ill Medical Patients
The Expert Circle
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
Did you know that hospitalized acutely ill medical patients remain at risk for venous thromboembolism (VTE) well past the time of discharge? In this short vlog, learn how to identify risk factors and avoid this complication as Dr. Mark Goldin shares a hospitalist’s perspective on the latest updates on postdischarge VTE prophylaxis for acutely ill medical patients. Dr. Goldin also discusses innovative interdisciplinary tools to promote appropriate postdischarge for these patients.
This activity is intended for clinical cardiologists, interventional cardiologists, hospitalists and primary care physicians.
The purpose of this activity is to provide learners with an engaging, accessible vlog activity to help them optimize postdischarge prophylaxis in their acutely ill medical patients. Expert faculty highlight the latest strategies (e.g. tools, EHR systems) to facilitate optimal postdischarge prophylaxis in this patient population. Learners post-activity will be better able to understand the importance of postdischarge prophylaxis in this patient population as well as interpret the latest data on DOACs as to develop VTE prophylaxis plans for these patients.
Upon completion of this activity, participants will be able to:
• Recognize the importance of optimal postdischarge prophylaxis for acutely ill medical patients
• Evaluate the latest safety and efficacy data for postdischarge prophylaxis in the acutely ill medical population
• Evaluate potential tools and strategies to facilitate proper postdischarge prophylaxis for acutely ill medical patients
• Recognize the importance of optimal postdischarge prophylaxis for acutely ill medical patients
• Evaluate the latest safety and efficacy data for postdischarge prophylaxis in the acutely ill medical population
• Evaluate potential tools and strategies to facilitate proper postdischarge prophylaxis for acutely ill medical patients
This activity is supported by an educational grant from Janssen Scientific Affairs, LLC.
This activity was part of a serial learning curriculum. This functionality is no longer available due to activity expiration.
Mark Goldin, MD
Associate Professor of Medicine
Zucker School of Medicine at Hofstra/Northwell
Hempstead, NY
Associate Professor of Medicine
Zucker School of Medicine at Hofstra/Northwell
Hempstead, NY
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity.
The following financial relationships have been provided:
Mark Goldin, MD
Grant/Research Support: Janssen
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 15 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 66% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
